DE60239386D1 - Zellbibliothek - Google Patents

Zellbibliothek

Info

Publication number
DE60239386D1
DE60239386D1 DE60239386T DE60239386T DE60239386D1 DE 60239386 D1 DE60239386 D1 DE 60239386D1 DE 60239386 T DE60239386 T DE 60239386T DE 60239386 T DE60239386 T DE 60239386T DE 60239386 D1 DE60239386 D1 DE 60239386D1
Authority
DE
Germany
Prior art keywords
novel
libraries
host cells
cell library
discovery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239386T
Other languages
English (en)
Inventor
Neil Goldsmith
Alexandra M Sorensen
Soren V Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evolva Holding SA
Original Assignee
Evolva AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolva AG filed Critical Evolva AG
Application granted granted Critical
Publication of DE60239386D1 publication Critical patent/DE60239386D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
DE60239386T 2001-01-25 2002-01-25 Zellbibliothek Expired - Lifetime DE60239386D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200100128 2001-01-25
DKPA200100679 2001-05-01
US30086301P 2001-06-27 2001-06-27
PCT/DK2002/000056 WO2002059297A2 (en) 2001-01-25 2002-01-25 A library of a collection of cells

Publications (1)

Publication Number Publication Date
DE60239386D1 true DE60239386D1 (de) 2011-04-21

Family

ID=43646216

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239386T Expired - Lifetime DE60239386D1 (de) 2001-01-25 2002-01-25 Zellbibliothek

Country Status (9)

Country Link
US (2) US7838287B2 (de)
EP (1) EP1356037B1 (de)
JP (2) JP2004525624A (de)
AT (1) ATE501251T1 (de)
AU (1) AU2002227883A1 (de)
CA (1) CA2474172C (de)
DE (1) DE60239386D1 (de)
DK (1) DK1356037T3 (de)
WO (1) WO2002059297A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008459B2 (en) 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
ATE501251T1 (de) 2001-01-25 2011-03-15 Evolva Ltd Zellbibliothek
AU2003237662B2 (en) * 2002-01-25 2008-04-24 Evolva Ltd Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
ES2368733T3 (es) 2002-07-18 2011-11-21 Merus B.V. Producción recombinante de mezclas de anticuerpos.
DK1529110T3 (da) * 2002-08-01 2012-01-30 Evolva Ltd Fremgangsmåde til blanding af store antal af heterologe gener
EP1639009B1 (de) 2003-05-30 2013-02-27 Merus B.V. Fab-bibliothek zur herstellung von einer mischung von antikörpern
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
JP5912211B2 (ja) * 2004-01-20 2016-04-27 メルス ビー．ヴィー． 結合タンパク質の混合物
AU2006227165B2 (en) 2005-03-18 2011-11-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
US8691555B2 (en) 2006-09-28 2014-04-08 Dsm Ip Assests B.V. Production of carotenoids in oleaginous yeast and fungi
EP2370451B1 (de) 2008-12-02 2016-11-16 Wave Life Sciences Japan, Inc. Verfahren zur synthese von am phosphoratom modifizierten nukleinsäuren
KR101153866B1 (ko) 2009-05-21 2012-06-27 대한민국 형질전환용 운반체, 이의 제조방법, 이를 이용한 형질전환방법 및 형질전환체
SG177564A1 (en) 2009-07-06 2012-02-28 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
US9476082B2 (en) 2010-05-20 2016-10-25 Evolva Sa Method of producing isoprenoid compounds in yeast
BR122021005287B1 (pt) 2010-06-02 2022-02-22 Evolva, Inc Hospedeiro recombinante que compreende um gene recombinante para produção de esteviol ou glicosídeo de esteviol
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ 不斉補助基
RU2014105311A (ru) 2011-07-19 2015-08-27 Уэйв Лайф Сайенсес Пте. Лтд. Способы синтеза функционализованных нуклеиновых кислот
SG10201606567TA (en) 2011-08-08 2016-10-28 Evolva Sa Recombinant production of steviol glycosides
EA202090591A3 (ru) 2012-04-20 2020-12-30 Мерюс Н.В. СПОСОБЫ И СРЕДСТВА ДЛЯ ПОЛУЧЕНИЯ Ig-ПОДОБНЫХ МОЛЕКУЛ
US10829772B2 (en) 2012-06-22 2020-11-10 Monsanto Technology Llc Unique modular vector design
SG11201500239VA (en) 2012-07-13 2015-03-30 Wave Life Sciences Japan Asymmetric auxiliary group
SG11201500243WA (en) 2012-07-13 2015-04-29 Shin Nippon Biomedical Lab Ltd Chiral nucleic acid adjuvant
US9982257B2 (en) 2012-07-13 2018-05-29 Wave Life Sciences Ltd. Chiral control
US20150293076A1 (en) * 2012-10-22 2015-10-15 Bolt Threads, Inc. Cellular Reprogramming for Product Optimization
KR20150115002A (ko) 2013-02-06 2015-10-13 에볼바 에스아 레바우디오시드 ｄ 및 레바우디오시드 ｍ의 개선된 생산 방법
BR112015019160A2 (pt) 2013-02-11 2017-08-22 Dalgaard Mikkelsen Michael Produção de glicosídeos de esteviol em hospedeiros recombinantes
JP6556122B2 (ja) 2013-09-17 2019-08-07 ボルト スレッズ インコーポレイテッド 改良シルク繊維を合成するための方法および組成物
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
JPWO2015108046A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
US10149905B2 (en) 2014-01-15 2018-12-11 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
DK3094728T3 (da) 2014-01-16 2022-05-16 Wave Life Sciences Ltd Kiralt design
SG11201700651RA (en) 2014-08-11 2017-02-27 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2016038095A2 (en) 2014-09-09 2016-03-17 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2016120486A1 (en) 2015-01-30 2016-08-04 Evolva Sa Production of steviol glycosides in recombinant hosts
CN107567492B (zh) 2015-03-16 2022-10-14 帝斯曼知识产权资产管理有限公司 Udp-糖基转移酶
AU2016307066A1 (en) 2015-08-07 2018-02-08 Evolva Sa Production of steviol glycosides in recombinant hosts
JP2019513392A (ja) 2016-04-13 2019-05-30 エヴォルヴァ エスアー．Ｅｖｏｌｖａ Ｓａ． 組み換え宿主におけるステビオールグリコシドの産生
US10815514B2 (en) 2016-05-16 2020-10-27 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2018053204A1 (en) 2016-09-14 2018-03-22 Bolt Threads, Inc. Long uniform recombinant protein fibers
US11396669B2 (en) 2016-11-07 2022-07-26 Evolva Sa Production of steviol glycosides in recombinant hosts
JP7212982B1 (ja) * 2022-10-05 2023-01-26 株式会社Logomix 細胞ライブラリおよびその製造方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341116C (en) 1983-02-22 2000-10-17 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
ATE116442T1 (de) 1988-04-22 1995-01-15 Massachusetts Inst Technology Verfahren zum formen und zum gebrauch von mikrotröpchen.
ATE160176T1 (de) 1989-07-07 1997-11-15 Unilever Nv Verfahren zur herstellung eines proteins mittels eines durch mehrfachkopieintegrierung eines expressionsvektors transformierten pilzes
US5316922A (en) * 1992-04-15 1994-05-31 The United States Of America As Represented By Department Of Health And Human Services Method for indentifying and expressing proteins that recognize and adhere to specific probes
US5482845A (en) 1993-09-24 1996-01-09 The Trustees Of Columbia University In The City Of New York Method for construction of normalized cDNA libraries
EP0730659A4 (de) 1993-10-27 1999-03-31 Univ Columbia Methode zur Bildung einersubtrahierten cDNA Bank und ihre Verwendung
US6268140B1 (en) * 1994-02-03 2001-07-31 Neugenesis Combinatorial metabolic libraries
US6309883B1 (en) * 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5837458A (en) * 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
AU723619B2 (en) * 1995-04-24 2000-08-31 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US6030779A (en) * 1995-07-18 2000-02-29 Diversa Corporation Screening for novel bioactivities
US6057103A (en) * 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
US5958672A (en) * 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
US6004788A (en) * 1995-07-18 1999-12-21 Diversa Corporation Enzyme kits and libraries
US20030215798A1 (en) 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US5939250A (en) * 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US20010041333A1 (en) * 1997-06-16 2001-11-15 Short Jay M. High throughput screening for a bioactivity or biomolecule
GB9603803D0 (en) * 1996-02-22 1996-04-24 Zeneca Ltd Production of proteins, plasmids coding therefor and organisms containing such plasmids
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US5783431A (en) * 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US6242211B1 (en) 1996-04-24 2001-06-05 Terragen Discovery, Inc. Methods for generating and screening novel metabolic pathways
WO1997044470A1 (en) 1996-05-21 1997-11-27 Novo Nordisk A/S Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast
US5763239A (en) * 1996-06-18 1998-06-09 Diversa Corporation Production and use of normalized DNA libraries
US6294325B1 (en) * 1996-07-05 2001-09-25 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of thermostable multi genes and proteins and uses thereof
AU6487196A (en) 1996-07-09 1998-02-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Transformation-associated recombination cloning
EP1007732B1 (de) 1997-01-17 2006-07-26 Maxygen, Inc. EVOLUTION Prokaryotischer GANZER ZELLEN DURCH REKURSIVE SEQUENZREKOMBINATION
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
JP3683591B2 (ja) 1997-02-27 2005-08-17 セロミックス インコーポレイテッド 細胞に基づくスクリーニングシステム
WO1998041869A1 (en) 1997-03-18 1998-09-24 Chromaxome Corporation Methods for screening compounds using encapsulated cells
US6391585B1 (en) 1997-05-27 2002-05-21 Hanil Synthetic Fiber Co., Ltd. Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae
GB9727512D0 (en) 1997-12-31 1998-02-25 Adprotech Plc Fuzzy genes and their application in molecular adjuvants
AU744699B2 (en) 1998-03-04 2002-02-28 Verenium Corporation Production and use of normalized DNA libraries
WO2000006715A1 (en) 1998-07-27 2000-02-10 Genotypes Inc. Automatic eukaryotic artificial chromosome vector
JP2002531056A (ja) 1998-08-07 2002-09-24 セレイ， エルエルシー 遺伝子分析におけるゲルマイクロドロップ
AU5696899A (en) 1998-08-31 2000-03-21 Maxygen, Inc. Transformation, selection, and screening of sequence-shuffled polynucleotides for development and optimization of plant phenotypes
AU6048599A (en) 1998-09-18 2000-04-10 Cellomics, Inc. A system for cell-based screening
IL145165A0 (en) 1999-03-09 2002-06-30 Diversa Corp End selection in directed evolution
CA2329122A1 (en) 1999-03-26 2000-10-05 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
GB9908814D0 (en) * 1999-04-16 1999-06-09 Celltech Therapeutics Ltd Process
AU7646000A (en) 1999-11-05 2001-05-14 Novozymes A/S Methods to screen microorganisms or gene libraries for products secreted from a cell
AU2001287273A1 (en) 2000-03-24 2001-10-08 Maxygen, Inc. Methods for modulating cellular and organismal phenotypes
CA2474146C (en) 2001-01-25 2012-09-18 Evolva Ltd. A method for evolving a cell having desired phenotype and evolved cells
ATE501251T1 (de) 2001-01-25 2011-03-15 Evolva Ltd Zellbibliothek
EP1360308B1 (de) 2001-01-25 2007-10-10 Evolva Ltd. Concatemere unterschiedlich exprimierter multipler gene
US8008459B2 (en) * 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
AU2002226307A1 (en) 2001-01-25 2002-08-06 Evolva Biotech A/S Artificial chromosomes comprising concatemers of expressible nucleotide sequences
AU2003237662B2 (en) * 2002-01-25 2008-04-24 Evolva Ltd Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities
EP1558741B1 (de) 2002-06-14 2008-02-20 Dyax Corporation Rekombination von nukleinsäurebibliotheksmitgliedern
US20030235823A1 (en) * 2002-06-24 2003-12-25 The University Of Alabama Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
DK1529110T3 (da) 2002-08-01 2012-01-30 Evolva Ltd Fremgangsmåde til blanding af store antal af heterologe gener

Also Published As

Publication number Publication date
EP1356037B1 (de) 2011-03-09
WO2002059297A3 (en) 2003-04-10
WO2002059297A2 (en) 2002-08-01
WO2002059297A8 (en) 2004-04-15
US7838287B2 (en) 2010-11-23
JP2004525624A (ja) 2004-08-26
CA2474172A1 (en) 2002-08-01
ATE501251T1 (de) 2011-03-15
US20120094870A1 (en) 2012-04-19
AU2002227883A1 (en) 2002-08-06
EP1356037A2 (de) 2003-10-29
DK1356037T3 (da) 2011-06-27
US20040241672A1 (en) 2004-12-02
JP4965625B2 (ja) 2012-07-04
JP2010043108A (ja) 2010-02-25
CA2474172C (en) 2012-07-10

Similar Documents

Publication Publication Date Title
ATE501251T1 (de) Zellbibliothek
Tang et al. LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis
Jason et al. Genome-wide CRISPR-Cas9 screening in mammalian cells
Montavon et al. Chromatin organization and global regulation of Hox gene clusters
Perino et al. Chromatin control of developmental dynamics and plasticity
Mao et al. Discovery of scmR as a global regulator of secondary metabolism and virulence in Burkholderia thailandensis E264
Jolly et al. Towards elucidating the connection between epithelial–mesenchymal transitions and stemness
Cohen et al. Histone modifiers in cancer: friends or foes?
Pawson et al. Network medicine
King et al. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates.
Friedman et al. Epigenomics and the structure of the living genome
Rao et al. Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
Corradi et al. Computational techniques are valuable tools for the discovery of protein–protein interaction inhibitors: the 14-3-3σ case
MX9708186A (es) Metodo para general y seleccionar rutas metabolicas novedosas.
DE60315723D1 (de) Herstellung von Polyketiden und anderen natürlichen Produkten
Zhalnina et al. Need for laboratory ecosystems to unravel the structures and functions of soil microbial communities mediated by chemistry
Cooper Rb, whi it's not just for metazoans anymore
WO2004072261A3 (en) Sirna libraries optimized for predetermined protein families
Liu et al. Small molecule therapeutics targeting F-box proteins in cancer
Taha et al. Synthesis, molecular docking study and thymidine phosphorylase inhibitory activity of 3-formylcoumarin derivatives
Palumbo et al. Kinetics effects and modeling of mRNA turnover
Quan et al. Chromatin structure changes during various processes from a DNA sequence view
Olsman et al. There's (still) plenty of room at the bottom
Chin Programming and engineering biological networks
Heng The genomic landscape of cancers

Legal Events

Date Code Title Description
R081 Change of applicant/patentee

Ref document number: 1356037

Country of ref document: EP

Owner name: EVOLVA LTD., CH

Free format text: FORMER OWNER: EVOLVA LTD., ALLSCHWIL, CH

Effective date: 20110705